-
1
-
-
78049485263
-
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
-
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127:2893-917
-
(2010)
Int J Cancer
, vol.127
, pp. 2893-2917
-
-
Ferlay, J.1
Shin, H.R.2
Bray, F.3
Forman, D.4
Mathers, C.5
Parkin, D.M.6
-
2
-
-
84924271853
-
Global cancer statistics, 2012
-
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65:87-108
-
(2015)
CA Cancer J Clin
, vol.65
, pp. 87-108
-
-
Torre, L.A.1
Bray, F.2
Siegel, R.L.3
Ferlay, J.4
Lortet-Tieulent, J.5
Jemal, A.6
-
6
-
-
85003554412
-
Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastases
-
Oct 10. [Epub ahead of print]
-
Beije N, Helmijr JC, Weerts MJ, Beaufort CM, Wiggin M, Marziali A, Verhoef C, Sleijfer S, Jansen MP, Martens JW. Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastases. Mol Oncol. 2016 Oct 10. doi: 10.1016/j.molonc.2016.10.001. [Epub ahead of print]
-
(2016)
Mol Oncol
-
-
Beije, N.1
Helmijr, J.C.2
Weerts, M.J.3
Beaufort, C.M.4
Wiggin, M.5
Marziali, A.6
Verhoef, C.7
Sleijfer, S.8
Jansen, M.P.9
Martens, J.W.10
-
7
-
-
84863000299
-
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
-
Diaz LA Jr, Williams RT, Wu J, Kinde I, Hecht JR, Berlin J, Allen B, Bozic I, Reiter JG, Nowak MA, Kinzler KW, Oliner KS, Vogelstein B. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature. 2012; 486:537-40
-
(2012)
Nature
, vol.486
, pp. 537-540
-
-
Diaz, L.A.1
Williams, R.T.2
Wu, J.3
Kinde, I.4
Hecht, J.R.5
Berlin, J.6
Allen, B.7
Bozic, I.8
Reiter, J.G.9
Nowak, M.A.10
Kinzler, K.W.11
Oliner, K.S.12
Vogelstein, B.13
-
8
-
-
84982298274
-
Colorectal cancer development and advances in screening
-
Simon K. Colorectal cancer development and advances in screening. Clin Interv Aging. 2016; 11:967-76
-
(2016)
Clin Interv Aging
, vol.11
, pp. 967-976
-
-
Simon, K.1
-
9
-
-
84931261902
-
Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma
-
Vukobrat-Bijedic Z, Husic-Selimovic A, Sofic A, Bijedic N, Bjelogrlic I, Gogov B, Mehmedovic A. Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma. Med Arch. 2013; 67:397-401
-
(2013)
Med Arch
, vol.67
, pp. 397-401
-
-
Vukobrat-Bijedic, Z.1
Husic-Selimovic, A.2
Sofic, A.3
Bijedic, N.4
Bjelogrlic, I.5
Gogov, B.6
Mehmedovic, A.7
-
10
-
-
40149104973
-
Colonography by CT, MRI and PET/CT combined with conventional colonoscopy in colorectal cancer screening and staging
-
Sun L. Colonography by CT, MRI and PET/CT combined with conventional colonoscopy in colorectal cancer screening and staging. World J Gastroenterol. 2008; 14:853-63
-
(2008)
World J Gastroenterol
, vol.14
, pp. 853-863
-
-
Sun, L.1
-
11
-
-
28544446695
-
Biomarkers in cancer staging, prognosis and treatment selection
-
Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer. 2005; 5:845-56
-
(2005)
Nat Rev Cancer
, vol.5
, pp. 845-856
-
-
Ludwig, J.A.1
Weinstein, J.N.2
-
12
-
-
84900333051
-
Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer
-
Lohr JG, Adalsteinsson VA, Cibulskis K, Choudhury AD, Rosenberg M, Cruz-Gordillo P, Francis JM, Zhang CZ, Shalek AK, Satija R, Trombetta JJ, Lu D, Tallapragada N, et al. Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer. Nat Biotechnol. 2014; 32:479-84
-
(2014)
Nat Biotechnol
, vol.32
, pp. 479-484
-
-
Lohr, J.G.1
Adalsteinsson, V.A.2
Cibulskis, K.3
Choudhury, A.D.4
Rosenberg, M.5
Cruz-Gordillo, P.6
Francis, J.M.7
Zhang, C.Z.8
Shalek, A.K.9
Satija, R.10
Trombetta, J.J.11
Lu, D.12
Tallapragada, N.13
-
13
-
-
84902959377
-
Detecting cancer by monitoring circulating tumor DNA
-
Spellman PT, Gray JW. Detecting cancer by monitoring circulating tumor DNA. Nat Med. 2014; 20:474-5
-
(2014)
Nat Med
, vol.20
, pp. 474-475
-
-
Spellman, P.T.1
Gray, J.W.2
-
14
-
-
84962393746
-
Reduced Proteolytic Shedding of Receptor Tyrosine Kinases is a Post-Translational Mechanism of Kinase Inhibitor Resistance
-
Miller MA, Oudin MJ, Sullivan RJ, Wang SJ, Meyer AS, Im H, Frederick DT, Tadros J, Griffith LG, Lee H, Weissleder R, Flaherty KT, Gertler FB, et al. Reduced Proteolytic Shedding of Receptor Tyrosine Kinases is a Post-Translational Mechanism of Kinase Inhibitor Resistance. Cancer Discov. 2016; 6:382-99
-
(2016)
Cancer Discov
, vol.6
, pp. 382-399
-
-
Miller, M.A.1
Oudin, M.J.2
Sullivan, R.J.3
Wang, S.J.4
Meyer, A.S.5
Im, H.6
Frederick, D.T.7
Tadros, J.8
Griffith, L.G.9
Lee, H.10
Weissleder, R.11
Flaherty, K.T.12
Gertler, F.B.13
-
15
-
-
84900307606
-
Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor
-
Im H, Shao H, Park YI, Peterson VM, Castro CM, Weissleder R, Lee H. Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor. Nat Biotechnol. 2014; 32:490-5
-
(2014)
Nat Biotechnol
, vol.32
, pp. 490-495
-
-
Im, H.1
Shao, H.2
Park, Y.I.3
Peterson, V.M.4
Castro, C.M.5
Weissleder, R.6
Lee, H.7
-
16
-
-
11944249676
-
Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer
-
Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J, Ratajczak MZ. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer. 2005; 113:752-60
-
(2005)
Int J Cancer
, vol.113
, pp. 752-760
-
-
Janowska-Wieczorek, A.1
Wysoczynski, M.2
Kijowski, J.3
Marquez-Curtis, L.4
Machalinski, B.5
Ratajczak, J.6
Ratajczak, M.Z.7
-
17
-
-
33746555498
-
Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells
-
Janowska-Wieczorek A, Marquez-Curtis LA, Wysoczynski M, Ratajczak MZ. Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells. Transfusion. 2006; 46:1199-209
-
(2006)
Transfusion
, vol.46
, pp. 1199-1209
-
-
Janowska-Wieczorek, A.1
Marquez-Curtis, L.A.2
Wysoczynski, M.3
Ratajczak, M.Z.4
-
18
-
-
84959176157
-
Clinical and biological significance of circulating tumor cells in cancer
-
Masuda T, Hayashi N, Iguchi T, Ito S, Eguchi H, Mimori K. Clinical and biological significance of circulating tumor cells in cancer. Mol Oncol. 2016; 10:408-17
-
(2016)
Mol Oncol
, vol.10
, pp. 408-417
-
-
Masuda, T.1
Hayashi, N.2
Iguchi, T.3
Ito, S.4
Eguchi, H.5
Mimori, K.6
-
19
-
-
84897445938
-
Circulating tumour cells: telling the truth about metastasis
-
Cristofanilli M. Circulating tumour cells: telling the truth about metastasis. Lancet Oncol. 2014; 15:365-6
-
(2014)
Lancet Oncol
, vol.15
, pp. 365-366
-
-
Cristofanilli, M.1
-
20
-
-
84945948733
-
Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer-20 Years of Progress
-
Hardingham JE, Grover P, Winter M, Hewett PJ, Price TJ, Thierry B. Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer-20 Years of Progress. Mol Med. 2015; 21:S25-31
-
(2015)
Mol Med
, vol.21
, pp. S25-S31
-
-
Hardingham, J.E.1
Grover, P.2
Winter, M.3
Hewett, P.J.4
Price, T.J.5
Thierry, B.6
-
21
-
-
33749031540
-
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer
-
Cohen SJ, Alpaugh RK, Gross S, O'Hara SM, Smirnov DA, Terstappen LW, Allard WJ, Bilbee M, Cheng JD, Hoffman JP, Lewis NL, Pellegrino A, Rogatko A, et al. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clin Colorectal Canc. 2006; 6:125-32
-
(2006)
Clin Colorectal Canc
, vol.6
, pp. 125-132
-
-
Cohen, S.J.1
Alpaugh, R.K.2
Gross, S.3
O'Hara, S.M.4
Smirnov, D.A.5
Terstappen, L.W.6
Allard, W.J.7
Bilbee, M.8
Cheng, J.D.9
Hoffman, J.P.10
Lewis, N.L.11
Pellegrino, A.12
Rogatko, A.13
-
22
-
-
49249130844
-
Relationship of circulating tumor cells to tumor response, progressionfree survival, and overall survival in patients with metastatic colorectal cancer
-
Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LW, et al. Relationship of circulating tumor cells to tumor response, progressionfree survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol. 2008; 26:3213-21
-
(2008)
J Clin Oncol
, vol.26
, pp. 3213-3221
-
-
Cohen, S.J.1
Punt, C.J.2
Iannotti, N.3
Saidman, B.H.4
Sabbath, K.D.5
Gabrail, N.Y.6
Picus, J.7
Morse, M.8
Mitchell, E.9
Miller, M.C.10
Doyle, G.V.11
Tissing, H.12
Terstappen, L.W.13
-
23
-
-
67650354361
-
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
-
Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse MA, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LW, et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann oncol. 2009; 20:1223-9
-
(2009)
Ann oncol
, vol.20
, pp. 1223-1229
-
-
Cohen, S.J.1
Punt, C.J.2
Iannotti, N.3
Saidman, B.H.4
Sabbath, K.D.5
Gabrail, N.Y.6
Picus, J.7
Morse, M.A.8
Mitchell, E.9
Miller, M.C.10
Doyle, G.V.11
Tissing, H.12
Terstappen, L.W.13
-
24
-
-
77954624770
-
Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer
-
Miller MC, Doyle GV, Terstappen LW. Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer. J Oncol. 2010; 2010:617421
-
(2010)
J Oncol
, vol.2010
-
-
Miller, M.C.1
Doyle, G.V.2
Terstappen, L.W.3
-
25
-
-
84864033569
-
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study
-
Sastre J, Maestro ML, Gomez-Espana A, Rivera F, Valladares M, Massuti B, Benavides M, Gallen M, Marcuello E, Abad A, Arrivi A, Fernandez-Martos C, Gonzalez E, et al. Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study. Oncologist. 2012; 17:947-55
-
(2012)
Oncologist
, vol.17
, pp. 947-955
-
-
Sastre, J.1
Maestro, M.L.2
Gomez-Espana, A.3
Rivera, F.4
Valladares, M.5
Massuti, B.6
Benavides, M.7
Gallen, M.8
Marcuello, E.9
Abad, A.10
Arrivi, A.11
Fernandez-Martos, C.12
Gonzalez, E.13
-
26
-
-
84907342688
-
Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis
-
Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, Brannigan BW, Kapur R, Stott SL, et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014; 158:1110-22
-
(2014)
Cell
, vol.158
, pp. 1110-1122
-
-
Aceto, N.1
Bardia, A.2
Miyamoto, D.T.3
Donaldson, M.C.4
Wittner, B.S.5
Spencer, J.A.6
Yu, M.7
Pely, A.8
Engstrom, A.9
Zhu, H.10
Brannigan, B.W.11
Kapur, R.12
Stott, S.L.13
-
27
-
-
84934437818
-
A microfluidic device for label-free, physical capture of circulating tumor cell clusters
-
Sarioglu AF, Aceto N, Kojic N, Donaldson MC, Zeinali M, Hamza B, Engstrom A, Zhu H, Sundaresan TK, Miyamoto DT, Luo X, Bardia A, Wittner BS, et al. A microfluidic device for label-free, physical capture of circulating tumor cell clusters. Nat Methods. 2015; 12:685-91
-
(2015)
Nat Methods
, vol.12
, pp. 685-691
-
-
Sarioglu, A.F.1
Aceto, N.2
Kojic, N.3
Donaldson, M.C.4
Zeinali, M.5
Hamza, B.6
Engstrom, A.7
Zhu, H.8
Sundaresan, T.K.9
Miyamoto, D.T.10
Luo, X.11
Bardia, A.12
Wittner, B.S.13
-
28
-
-
85007432816
-
Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by alabel-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer
-
Kidess-Sigal E, Liu HE, Triboulet MM, Che J, Ramani VC, Visser BC, Poultsides GA, Longacre TA, Marziali A, Vysotskaia V, Wiggin M, Heirich K, Hanft V, et al. Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by alabel-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer. Oncotarget. 2016; 7:85349-85364. doi: 10.18632/oncotarget.13350
-
(2016)
Oncotarget
, vol.7
, pp. 85349-85364
-
-
Kidess-Sigal, E.1
Liu, H.E.2
Triboulet, M.M.3
Che, J.4
Ramani, V.C.5
Visser, B.C.6
Poultsides, G.A.7
Longacre, T.A.8
Marziali, A.9
Vysotskaia, V.10
Wiggin, M.11
Heirich, K.12
Hanft, V.13
-
29
-
-
84891880112
-
Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications
-
Harouaka R, Kang Z, Zheng SY, Cao L. Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications. Pharmacol Ther. 2014; 141:209-21
-
(2014)
Pharmacol Ther
, vol.141
, pp. 209-221
-
-
Harouaka, R.1
Kang, Z.2
Zheng, S.Y.3
Cao, L.4
-
30
-
-
84905174495
-
Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAMbased methodology for basic and clinical cancer research
-
Grover PK, Cummins AG, Price TJ, Roberts-Thomson IC, Hardingham JE. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAMbased methodology for basic and clinical cancer research. Ann Oncol. 2014; 25:1506-16
-
(2014)
Ann Oncol
, vol.25
, pp. 1506-1516
-
-
Grover, P.K.1
Cummins, A.G.2
Price, T.J.3
Roberts-Thomson, I.C.4
Hardingham, J.E.5
-
31
-
-
24644451986
-
Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors
-
Rao C, Chianese D, Doyle G, Miller M, Russell T, Sanders R, Terstappen L. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int J Oncol. 2005; 27:49-57
-
(2005)
Int J Oncol
, vol.27
, pp. 49-57
-
-
Rao, C.1
Chianese, D.2
Doyle, G.3
Miller, M.4
Russell, T.5
Sanders, R.6
Terstappen, L.7
-
32
-
-
79954496657
-
Comparison of three distinct methods for the detection of circulating tumor cells in colorectal cancer patients
-
Gervasoni A, Sandri MT, Nascimbeni R, Zorzino L, Cassatella MC, Baglioni L, Panigara S, Gervasi M, Di Lorenzo D, Parolini O. Comparison of three distinct methods for the detection of circulating tumor cells in colorectal cancer patients. Oncol Rep. 2011; 25:1669-703
-
(2011)
Oncol Rep
, vol.25
, pp. 1669-1703
-
-
Gervasoni, A.1
Sandri, M.T.2
Nascimbeni, R.3
Zorzino, L.4
Cassatella, M.C.5
Baglioni, L.6
Panigara, S.7
Gervasi, M.8
Di Lorenzo, D.9
Parolini, O.10
-
33
-
-
55149102183
-
Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis
-
Katsuno H, Zacharakis E, Aziz O, Rao C, Deeba S, Paraskeva P, Ziprin P, Athanasiou T, Darzi A. Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis. Ann Surg Oncol. 2008; 15:3083-91
-
(2008)
Ann Surg Oncol
, vol.15
, pp. 3083-3091
-
-
Katsuno, H.1
Zacharakis, E.2
Aziz, O.3
Rao, C.4
Deeba, S.5
Paraskeva, P.6
Ziprin, P.7
Athanasiou, T.8
Darzi, A.9
-
34
-
-
79955030814
-
Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer
-
Iinuma H, Watanabe T, Mimori K, Adachi M, Hayashi N, Tamura J, Matsuda K, Fukushima R, Okinaga K, Sasako M, Mori M. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. J Clin Oncol. 2011; 29:1547-55
-
(2011)
J Clin Oncol
, vol.29
, pp. 1547-1555
-
-
Iinuma, H.1
Watanabe, T.2
Mimori, K.3
Adachi, M.4
Hayashi, N.5
Tamura, J.6
Matsuda, K.7
Fukushima, R.8
Okinaga, K.9
Sasako, M.10
Mori, M.11
-
35
-
-
0035866393
-
DNA Fragments in the Blood Plasma of Cancer Patients: Quantitations and Evidence for Their Origin from Apoptotic and Necrotic Cells
-
Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R. DNA Fragments in the Blood Plasma of Cancer Patients: Quantitations and Evidence for Their Origin from Apoptotic and Necrotic Cells. Cancer Res. 2001; 61:1659-65
-
(2001)
Cancer Res
, vol.61
, pp. 1659-1665
-
-
Jahr, S.1
Hentze, H.2
Englisch, S.3
Hardt, D.4
Fackelmayer, F.O.5
Hesch, R.D.6
Knippers, R.7
-
36
-
-
84982840399
-
Fragment Length of Circulating Tumor DNA
-
Underhill HR, Kitzman JO, Hellwig S, Welker NC, Daza R, Baker DN, Gligorich KM, Rostomily RC, Bronner MP, Shendure J. Fragment Length of Circulating Tumor DNA. PLoS Genet. 2016; 12:e1006162
-
(2016)
PLoS Genet
, vol.12
-
-
Underhill, H.R.1
Kitzman, J.O.2
Hellwig, S.3
Welker, N.C.4
Daza, R.5
Baker, D.N.6
Gligorich, K.M.7
Rostomily, R.C.8
Bronner, M.P.9
Shendure, J.10
-
37
-
-
84920508228
-
Circulating tumor DNA as a liquid biopsy for cancer
-
Heitzer E, Ulz P, Geigl JB. Circulating tumor DNA as a liquid biopsy for cancer. Clin Chem. 2015; 61:112-23
-
(2015)
Clin Chem
, vol.61
, pp. 112-123
-
-
Heitzer, E.1
Ulz, P.2
Geigl, J.B.3
-
38
-
-
0033364339
-
Rapid clearance of fetal DNA from maternal plasma
-
Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet. 1999; 64:218-24
-
(1999)
Am J Hum Genet
, vol.64
, pp. 218-224
-
-
Lo, Y.M.1
Zhang, J.2
Leung, T.N.3
Lau, T.K.4
Chang, A.M.5
Hjelm, N.M.6
-
39
-
-
51349141191
-
Circulating mutant DNA to assess tumor dynamics
-
Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo SA, Kinzler KW, Vogelstein B, Diaz LA Jr. Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008; 14:985-90
-
(2008)
Nat Med
, vol.14
, pp. 985-990
-
-
Diehl, F.1
Schmidt, K.2
Choti, M.A.3
Romans, K.4
Goodman, S.5
Li, M.6
Thornton, K.7
Agrawal, N.8
Sokoll, L.9
Szabo, S.A.10
Kinzler, K.W.11
Vogelstein, B.12
Diaz, L.A.13
-
40
-
-
28044468634
-
Detection and quantification of mutations in the plasma of patients with colorectal tumors
-
Diehl F, Li M, Dressman D, He Y, Shen D, Szabo S, Diaz LA Jr, Goodman SN, David KA, Juhl H, Kinzler KW, Vogelstein B. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci U S A. 2005; 102:16368-73
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 16368-16373
-
-
Diehl, F.1
Li, M.2
Dressman, D.3
He, Y.4
Shen, D.5
Szabo, S.6
Diaz, L.A.7
Goodman, S.N.8
David, K.A.9
Juhl, H.10
Kinzler, K.W.11
Vogelstein, B.12
-
41
-
-
0642311916
-
Quantification of free circulating DNA as a diagnostic marker in lung cancer
-
Sozzi G, Conte D, Leon M, Ciricione R, Roz L, Ratcliffe C, Roz E, Cirenei N, Bellomi M, Pelosi G, Pierotti MA, Pastorino U. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol. 2003; 21:3902-8
-
(2003)
J Clin Oncol
, vol.21
, pp. 3902-3908
-
-
Sozzi, G.1
Conte, D.2
Leon, M.3
Ciricione, R.4
Roz, L.5
Ratcliffe, C.6
Roz, E.7
Cirenei, N.8
Bellomi, M.9
Pelosi, G.10
Pierotti, M.A.11
Pastorino, U.12
-
42
-
-
41649114743
-
Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer
-
Frattini M, Gallino G, Signoroni S, Balestra D, Lusa L, Battaglia L, Sozzi G, Bertario L, Leo E, Pilotti S, Pierotti MA. Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer. Cancer Lett. 2008; 263:170-81
-
(2008)
Cancer Lett
, vol.263
, pp. 170-181
-
-
Frattini, M.1
Gallino, G.2
Signoroni, S.3
Balestra, D.4
Lusa, L.5
Battaglia, L.6
Sozzi, G.7
Bertario, L.8
Leo, E.9
Pilotti, S.10
Pierotti, M.A.11
-
43
-
-
0042334866
-
Rapid Clearance of Plasma Epstein-Barr Virus DNA After Surgical Treatment of Nasopharyngeal Carcinoma
-
To EW, Chan KC, Leung SF, Chan LY, To KF, Chan AT, Johnson PJ, Lo YM. Rapid Clearance of Plasma Epstein-Barr Virus DNA After Surgical Treatment of Nasopharyngeal Carcinoma. Clin Cancer Res. 2003; 9:3254-9
-
(2003)
Clin Cancer Res
, vol.9
, pp. 3254-3259
-
-
To, E.W.1
Chan, K.C.2
Leung, S.F.3
Chan, L.Y.4
To, K.F.5
Chan, A.T.6
Johnson, P.J.7
Lo, Y.M.8
-
44
-
-
84877578956
-
Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program
-
Chan KC, Hung EC, Woo JK, Chan PK, Leung SF, Lai FP, Cheng AS, Yeung SW, Chan YW, Tsui TK, Kwok JS, King AD, Chan AT, et al. Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program. Cancer. 2013; 119:1838-44
-
(2013)
Cancer
, vol.119
, pp. 1838-1844
-
-
Chan, K.C.1
Hung, E.C.2
Woo, J.K.3
Chan, P.K.4
Leung, S.F.5
Lai, F.P.6
Cheng, A.S.7
Yeung, S.W.8
Chan, Y.W.9
Tsui, T.K.10
Kwok, J.S.11
King, A.D.12
Chan, A.T.13
-
45
-
-
84891743167
-
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
-
Church TR, Wandell M, Lofton-Day C, Mongin SJ, Burger M, Payne SR, Castanos-Velez E, Blumenstein BA, Rosch T, Osborn N, Snover D, Day RW, RansohoffDF, et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut. 2014; 63:317-25
-
(2014)
Gut
, vol.63
, pp. 317-325
-
-
Church, T.R.1
Wandell, M.2
Lofton-Day, C.3
Mongin, S.J.4
Burger, M.5
Payne, S.R.6
Castanos-Velez, E.7
Blumenstein, B.A.8
Rosch, T.9
Osborn, N.10
Snover, D.11
Day, R.W.12
Ransohoff, D.F.13
-
46
-
-
84896371874
-
Detection of circulating tumor DNA in early-and late-stage human malignancies
-
Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, Antonarakis ES, Azad NS, Bardelli A, et al. Detection of circulating tumor DNA in early-and late-stage human malignancies. Sci Transl Med. 2014; 6:224ra224
-
(2014)
Sci Transl Med
, vol.6
-
-
Bettegowda, C.1
Sausen, M.2
Leary, R.J.3
Kinde, I.4
Wang, Y.5
Agrawal, N.6
Bartlett, B.R.7
Wang, H.8
Luber, B.9
Alani, R.M.10
Antonarakis, E.S.11
Azad, N.S.12
Bardelli, A.13
-
47
-
-
85014091144
-
Integrating liquid biopsies into the management of cancer
-
Mar 2. [Epub ahead of print]
-
Siravegna G, Marsoni S, Siena S, Bardelli A. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. 2017 Mar 2. doi: 10.1038/nrclinonc.2017.14. [Epub ahead of print]
-
(2017)
Nat Rev Clin Oncol
-
-
Siravegna, G.1
Marsoni, S.2
Siena, S.3
Bardelli, A.4
-
48
-
-
84874377202
-
Extracellular vesicles: exosomes, microvesicles, and friends
-
Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013; 200:373-83
-
(2013)
J Cell Biol
, vol.200
, pp. 373-383
-
-
Raposo, G.1
Stoorvogel, W.2
-
49
-
-
76649094917
-
Proteomics Analysis of A33 Immunoaffinity-purified Exosomes Released from the Human Colon Tumor Cell Line LIM1215 Reveals a Tissue-specific Protein Signature
-
Mathivanan S, Lim JW, Tauro BJ, Ji H, Moritz RL, Simpson RJ. Proteomics Analysis of A33 Immunoaffinity-purified Exosomes Released from the Human Colon Tumor Cell Line LIM1215 Reveals a Tissue-specific Protein Signature. Mol Cell Proteomics. 2010; 9:197-208
-
(2010)
Mol Cell Proteomics
, vol.9
, pp. 197-208
-
-
Mathivanan, S.1
Lim, J.W.2
Tauro, B.J.3
Ji, H.4
Moritz, R.L.5
Simpson, R.J.6
-
50
-
-
84978498961
-
Microfluidic Exosome Analysis toward Liquid Biopsy for Cancer
-
He M, Zeng Y. Microfluidic Exosome Analysis toward Liquid Biopsy for Cancer. J Lab Autom. 2016; 21:599-608
-
(2016)
J Lab Autom
, vol.21
, pp. 599-608
-
-
He, M.1
Zeng, Y.2
-
51
-
-
84862007577
-
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
-
Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, García-Santos G, Ghajar CM, Nitadori-Hoshino A, Hoffman C, Badal K, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012; 18:883-91
-
(2012)
Nat Med
, vol.18
, pp. 883-891
-
-
Peinado, H.1
Aleckovic, M.2
Lavotshkin, S.3
Matei, I.4
Costa-Silva, B.5
Moreno-Bueno, G.6
Hergueta-Redondo, M.7
Williams, C.8
García-Santos, G.9
Ghajar, C.M.10
Nitadori-Hoshino, A.11
Hoffman, C.12
Badal, K.13
-
52
-
-
84947723880
-
Tumour exosome integrins determine organotropic metastasis
-
Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015; 527:329-35
-
(2015)
Nature
, vol.527
, pp. 329-335
-
-
Hoshino, A.1
Costa-Silva, B.2
Shen, T.L.3
Rodrigues, G.4
Hashimoto, A.5
Tesic Mark, M.6
Molina, H.7
Kohsaka, S.8
Di Giannatale, A.9
Ceder, S.10
Singh, S.11
Williams, C.12
Soplop, N.13
-
53
-
-
33747616431
-
Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication
-
Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia. 2006; 20:1487-95
-
(2006)
Leukemia
, vol.20
, pp. 1487-1495
-
-
Ratajczak, J.1
Wysoczynski, M.2
Hayek, F.3
Janowska-Wieczorek, A.4
Ratajczak, M.Z.5
-
54
-
-
84901842265
-
Double-stranded DNA in exosomes: a novel biomarker in cancer detection
-
Thakur BK, Zhang H, Becker A, Matei I, Huang Y, Costa-Silva B, Zheng Y, Hoshino A, Brazier H, Xiang J, Williams C, Rodriguez-Barrueco R, Silva JM, et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 2014; 24:766-9
-
(2014)
Cell Res
, vol.24
, pp. 766-769
-
-
Thakur, B.K.1
Zhang, H.2
Becker, A.3
Matei, I.4
Huang, Y.5
Costa-Silva, B.6
Zheng, Y.7
Hoshino, A.8
Brazier, H.9
Xiang, J.10
Williams, C.11
Rodriguez-Barrueco, R.12
Silva, J.M.13
-
55
-
-
4143094988
-
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
-
Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LM, Hayes DF. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004; 351:781-91
-
(2004)
N Engl J Med
, vol.351
, pp. 781-791
-
-
Cristofanilli, M.1
Budd, G.T.2
Ellis, M.J.3
Stopeck, A.4
Matera, J.5
Miller, M.C.6
Reuben, J.M.7
Doyle, G.V.8
Allard, W.J.9
Terstappen, L.M.10
Hayes, D.F.11
-
56
-
-
84897445481
-
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
-
Bidard FC, Peeters DJ, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Generali D, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, et al. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. Lancet Oncol. 2014; 15:406-14
-
(2014)
Lancet Oncol
, vol.15
, pp. 406-414
-
-
Bidard, F.C.1
Peeters, D.J.2
Fehm, T.3
Nolé, F.4
Gisbert-Criado, R.5
Mavroudis, D.6
Grisanti, S.7
Generali, D.8
Garcia-Saenz, J.A.9
Stebbing, J.10
Caldas, C.11
Gazzaniga, P.12
Manso, L.13
-
57
-
-
84959093230
-
Functional studies on circulating and disseminated tumor cells in carcinoma patients
-
Alix-Panabières C, Bartkowiak K, Pantel K. Functional studies on circulating and disseminated tumor cells in carcinoma patients. Mol Oncol. 2016; 10:443-9
-
(2016)
Mol Oncol
, vol.10
, pp. 443-449
-
-
Alix-Panabières, C.1
Bartkowiak, K.2
Pantel, K.3
-
58
-
-
84883375246
-
Capture of Viable Circulating Tumor Cells in the Liver of Colorectal Cancer Patients
-
Deneve E, Riethdorf S, Ramos J, Nocca D, Coffy A, Daures JP, Maudelonde T, Fabre JM, Pantel K, Alix-Panabieres C. Capture of Viable Circulating Tumor Cells in the Liver of Colorectal Cancer Patients. Clin Chem. 2013; 59:1384-92
-
(2013)
Clin Chem
, vol.59
, pp. 1384-1392
-
-
Deneve, E.1
Riethdorf, S.2
Ramos, J.3
Nocca, D.4
Coffy, A.5
Daures, J.P.6
Maudelonde, T.7
Fabre, J.M.8
Pantel, K.9
Alix-Panabieres, C.10
-
59
-
-
84879549503
-
Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer
-
Ligthart ST, Coumans FA, Bidard FC, Simkens LH, Punt CJ, de Groot MR, Attard G, de Bono JS, Perga JY, Terstappen LW. Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer. PLoS One. 2013; 8:e67148
-
(2013)
PLoS One
, vol.8
-
-
Ligthart, S.T.1
Coumans, F.A.2
Bidard, F.C.3
Simkens, L.H.4
Punt, C.J.5
de Groot, M.R.6
Attard, G.7
de Bono, J.S.8
Perga, J.Y.9
Terstappen, L.W.10
-
60
-
-
84928211139
-
Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study
-
Bork U, Rahbari NN, Scholch S, Reissfelder C, Kahlert C, Buchler MW, Weitz J, Koch M. Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study. Br J Cancer. 2015; 112:1306-13
-
(2015)
Br J Cancer
, vol.112
, pp. 1306-1313
-
-
Bork, U.1
Rahbari, N.N.2
Scholch, S.3
Reissfelder, C.4
Kahlert, C.5
Buchler, M.W.6
Weitz, J.7
Koch, M.8
-
61
-
-
85011954008
-
Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer
-
Zhao R, Cai Z, Li S, Cheng Y, Gao H, Liu F, Wu S, Liu S, Dong Y, Zheng L, Zhang W, Wu X, Yao X. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer. Oncotarget. 2017; 8:9293-9302. doi: 10.18632/oncotarget.14065
-
(2017)
Oncotarget
, vol.8
, pp. 9293-9302
-
-
Zhao, R.1
Cai, Z.2
Li, S.3
Cheng, Y.4
Gao, H.5
Liu, F.6
Wu, S.7
Liu, S.8
Dong, Y.9
Zheng, L.10
Zhang, W.11
Wu, X.12
Yao, X.13
-
62
-
-
84928698890
-
Establishment and characterization of a cell line from human circulating colon cancer cells
-
Cayrefourcq L, Mazard T, Joosse S, Solassol J, Ramos J, Assenat E, Schumacher U, Costes V, Maudelonde T, Pantel K, Alix-Panabieres C. Establishment and characterization of a cell line from human circulating colon cancer cells. Cancer Res. 2015; 75:892-901
-
(2015)
Cancer Res
, vol.75
, pp. 892-901
-
-
Cayrefourcq, L.1
Mazard, T.2
Joosse, S.3
Solassol, J.4
Ramos, J.5
Assenat, E.6
Schumacher, U.7
Costes, V.8
Maudelonde, T.9
Pantel, K.10
Alix-Panabieres, C.11
-
63
-
-
84979622730
-
-
Gut. Jul 25. [Epub ahead of print]
-
Grillet F, Bayet E, Villeronce O, Zappia L, Lagerqvist EL, Lunke S, Charafe-Jauffret E, Pham K, Molck C, Rolland N, Bourgaux JF, Prudhomme M, Philippe C, et al. Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture. Gut. 2016 Jul 25. doi: 10.1136/gutjnl-2016-311447. [Epub ahead of print]
-
(2016)
Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture
-
-
Grillet, F.1
Bayet, E.2
Villeronce, O.3
Zappia, L.4
Lagerqvist, E.L.5
Lunke, S.6
Charafe-Jauffret, E.7
Pham, K.8
Molck, C.9
Rolland, N.10
Bourgaux, J.F.11
Prudhomme, M.12
Philippe, C.13
-
64
-
-
54949085398
-
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
-
Karapetis CS, Khambata-Ford S, Jonker DJ, O'Callaghan CJ, Tu D, Tebbutt NC, Simes RJ, Chalchal H, Shapiro JD, Robitaille S, Price TJ, Shepherd L, Au HJ, et al. K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer. N Engl J Med. 2008; 359:1757-65
-
(2008)
N Engl J Med
, vol.359
, pp. 1757-1765
-
-
Karapetis, C.S.1
Khambata-Ford, S.2
Jonker, D.J.3
O'Callaghan, C.J.4
Tu, D.5
Tebbutt, N.C.6
Simes, R.J.7
Chalchal, H.8
Shapiro, J.D.9
Robitaille, S.10
Price, T.J.11
Shepherd, L.12
Au, H.J.13
-
65
-
-
84893962650
-
Tumor heterogeneity revealed by KRAS, BRAF, and PIK3CA pyrosequencing: KRAS and PIK3CA intratumor mutation profile differences and their therapeutic implications
-
Kosmidou V, Oikonomou E, Vlassi M, Avlonitis S, Katseli A, Tsipras I, Mourtzoukou D, Kontogeorgos G, Zografos G, Pintzas A. Tumor heterogeneity revealed by KRAS, BRAF, and PIK3CA pyrosequencing: KRAS and PIK3CA intratumor mutation profile differences and their therapeutic implications. Hum Mutat. 2014; 35:329-40
-
(2014)
Hum Mutat
, vol.35
, pp. 329-340
-
-
Kosmidou, V.1
Oikonomou, E.2
Vlassi, M.3
Avlonitis, S.4
Katseli, A.5
Tsipras, I.6
Mourtzoukou, D.7
Kontogeorgos, G.8
Zografos, G.9
Pintzas, A.10
-
66
-
-
84878453265
-
Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs
-
Fabbri F, Carloni S, Zoli W, Ulivi P, Gallerani G, Fici P, Chiadini E, Passardi A, Frassineti GL, Ragazzini A, Amadori D. Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs. Cancer Lett. 2013; 335:225-31
-
(2013)
Cancer Lett
, vol.335
, pp. 225-231
-
-
Fabbri, F.1
Carloni, S.2
Zoli, W.3
Ulivi, P.4
Gallerani, G.5
Fici, P.6
Chiadini, E.7
Passardi, A.8
Frassineti, G.L.9
Ragazzini, A.10
Amadori, D.11
-
67
-
-
84885430462
-
Circulating tumor cells in high-risk nonmetastatic colorectal cancer
-
Gazzaniga P, Gianni W, Raimondi C, Gradilone A, Lo Russo G, Longo F, Gandini O, Tomao S, Frati L. Circulating tumor cells in high-risk nonmetastatic colorectal cancer. Tumour Biol. 2013; 34:2507-9
-
(2013)
Tumour Biol
, vol.34
, pp. 2507-2509
-
-
Gazzaniga, P.1
Gianni, W.2
Raimondi, C.3
Gradilone, A.4
Lo Russo, G.5
Longo, F.6
Gandini, O.7
Tomao, S.8
Frati, L.9
-
68
-
-
84941630950
-
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
-
Tie J, Kinde I, Wang Y, Wong HL, Roebert J, Christie M, Tacey M, Wong R, Singh M, Karapetis CS, Desai J, Tran B, Strausberg RL, et al. Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. Ann Oncol. 2015; 26:1715-22
-
(2015)
Ann Oncol
, vol.26
, pp. 1715-1722
-
-
Tie, J.1
Kinde, I.2
Wang, Y.3
Wong, H.L.4
Roebert, J.5
Christie, M.6
Tacey, M.7
Wong, R.8
Singh, M.9
Karapetis, C.S.10
Desai, J.11
Tran, B.12
Strausberg, R.L.13
-
69
-
-
84978062740
-
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
-
Tie J, Wang Y, Tomasetti C, Li L, Springer S, Kinde I, Silliman N, Tacey M, Wong HL, Christie M, Kosmider S, Skinner I, Wong R, et al. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci Transl Med. 2016; 8:346ra92
-
(2016)
Sci Transl Med
, vol.8
-
-
Tie, J.1
Wang, Y.2
Tomasetti, C.3
Li, L.4
Springer, S.5
Kinde, I.6
Silliman, N.7
Tacey, M.8
Wong, H.L.9
Christie, M.10
Kosmider, S.11
Skinner, I.12
Wong, R.13
-
70
-
-
84980011736
-
A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker
-
Garrigou S, Perkins G, Garlan F, Normand C, Didelot A, Le Corre D, Peyvandi S, Mulot C, Niarra R, Aucouturier P, Chatellier G, Nizard P, Perez-Toralla K, et al. A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker. Clin Chem. 2016; 62:1129-39
-
(2016)
Clin Chem
, vol.62
, pp. 1129-1139
-
-
Garrigou, S.1
Perkins, G.2
Garlan, F.3
Normand, C.4
Didelot, A.5
Le Corre, D.6
Peyvandi, S.7
Mulot, C.8
Niarra, R.9
Aucouturier, P.10
Chatellier, G.11
Nizard, P.12
Perez-Toralla, K.13
-
71
-
-
85008450713
-
Diagnostic and prognostic role of cellfree DNA testing for colorectal cancer patients
-
Bedin C, Enzo MV, Del Bianco P, Pucciarelli S, Nitti D, Agostini M. Diagnostic and prognostic role of cellfree DNA testing for colorectal cancer patients. Int J Cancer. 2017; 140:1888-1898
-
(2017)
Int J Cancer
, vol.140
, pp. 1888-1898
-
-
Bedin, C.1
Enzo, M.V.2
Del Bianco, P.3
Pucciarelli, S.4
Nitti, D.5
Agostini, M.6
-
72
-
-
84862999938
-
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
-
Misale S, Yaeger R, Hobor S, Scala E, Janakiraman M, Liska D, Valtorta E, Schiavo R, Buscarino M, Siravegna G, Bencardino K, Cercek A, Chen CT, et al. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature. 2012; 486:532-6
-
(2012)
Nature
, vol.486
, pp. 532-536
-
-
Misale, S.1
Yaeger, R.2
Hobor, S.3
Scala, E.4
Janakiraman, M.5
Liska, D.6
Valtorta, E.7
Schiavo, R.8
Buscarino, M.9
Siravegna, G.10
Bencardino, K.11
Cercek, A.12
Chen, C.T.13
-
73
-
-
84898476658
-
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
-
Thierry AR, Mouliere F, El Messaoudi S, Mollevi C, Lopez-Crapez E, Rolet F, Gillet B, Gongora C, Dechelotte P, Robert B, Del Rio M, Lamy PJ, Bibeau F, et al. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. Nat Med. 2014; 20:430-5
-
(2014)
Nat Med
, vol.20
, pp. 430-435
-
-
Thierry, A.R.1
Mouliere, F.2
El Messaoudi, S.3
Mollevi, C.4
Lopez-Crapez, E.5
Rolet, F.6
Gillet, B.7
Gongora, C.8
Dechelotte, P.9
Robert, B.10
Del Rio, M.11
Lamy, P.J.12
Bibeau, F.13
-
74
-
-
84875490185
-
Cancer Genome Landscapes
-
Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW. Cancer Genome Landscapes. Science. 2013; 339:1546-58
-
(2013)
Science
, vol.339
, pp. 1546-1558
-
-
Vogelstein, B.1
Papadopoulos, N.2
Velculescu, V.E.3
Zhou, S.4
Diaz, L.A.5
Kinzler, K.W.6
-
75
-
-
84936748494
-
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
-
Siravegna G, Mussolin B, Buscarino M, Corti G, Cassingena A, Crisafulli G, Ponzetti A, Cremolini C, Amatu A, Lauricella C, Lamba S, Hobor S, Avallone A, et al. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nat Med. 2015; 21:795-801
-
(2015)
Nat Med
, vol.21
, pp. 795-801
-
-
Siravegna, G.1
Mussolin, B.2
Buscarino, M.3
Corti, G.4
Cassingena, A.5
Crisafulli, G.6
Ponzetti, A.7
Cremolini, C.8
Amatu, A.9
Lauricella, C.10
Lamba, S.11
Hobor, S.12
Avallone, A.13
-
76
-
-
84906245875
-
Changes in mutational status during third-line treatment for metastatic colorectal cancer-results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasma
-
Spindler KL, Pallisgaard N, Andersen RF, Jakobsen A. Changes in mutational status during third-line treatment for metastatic colorectal cancer-results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasma. Int J Cancer. 2014; 135:2215-22
-
(2014)
Int J Cancer
, vol.135
, pp. 2215-2222
-
-
Spindler, K.L.1
Pallisgaard, N.2
Andersen, R.F.3
Jakobsen, A.4
-
77
-
-
84877579861
-
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
-
Murtaza M, Dawson SJ, Tsui DW, Gale D, Forshew T, Piskorz AM, Parkinson C, Chin SF, Kingsbury Z, Wong AS, Marass F, Humphray S, Hadfield J, et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature. 2013; 497:108-12
-
(2013)
Nature
, vol.497
, pp. 108-112
-
-
Murtaza, M.1
Dawson, S.J.2
Tsui, D.W.3
Gale, D.4
Forshew, T.5
Piskorz, A.M.6
Parkinson, C.7
Chin, S.F.8
Kingsbury, Z.9
Wong, A.S.10
Marass, F.11
Humphray, S.12
Hadfield, J.13
-
78
-
-
84998996876
-
The Oxford Nanopore MinION: delivery of nanopore sequencing to the genomics community
-
Jain M, Olsen HE, Paten B, Akeson M. The Oxford Nanopore MinION: delivery of nanopore sequencing to the genomics community. Genome Biol. 2016; 17:239
-
(2016)
Genome Biol
, vol.17
, pp. 239
-
-
Jain, M.1
Olsen, H.E.2
Paten, B.3
Akeson, M.4
-
79
-
-
53649108801
-
The potential and challenges of nanopore sequencing
-
Branton D, Deamer DW, Marziali A, Bayley H, Benner SA, Butler T, Di Ventra M, Garaj S, Hibbs A, Huang X, Jovanovich SB, Krstic PS, Lindsay S, et al. The potential and challenges of nanopore sequencing. Nat Biotechnol. 2008; 26:1146-53
-
(2008)
Nat Biotechnol
, vol.26
, pp. 1146-1153
-
-
Branton, D.1
Deamer, D.W.2
Marziali, A.3
Bayley, H.4
Benner, S.A.5
Butler, T.6
Di Ventra, M.7
Garaj, S.8
Hibbs, A.9
Huang, X.10
Jovanovich, S.B.11
Krstic, P.S.12
Lindsay, S.13
-
80
-
-
84899431845
-
Circulating Exosomal microRNAs as Biomarkers of Colon Cancer
-
Ogata-Kawata H, Izumiya M, Kurioka D, Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H, Watanabe M, Nakagama H, Yokota J, et al. Circulating Exosomal microRNAs as Biomarkers of Colon Cancer. PLoS ONE. 2014; 9:e92921
-
(2014)
PLoS ONE
, vol.9
-
-
Ogata-Kawata, H.1
Izumiya, M.2
Kurioka, D.3
Honma, Y.4
Yamada, Y.5
Furuta, K.6
Gunji, T.7
Ohta, H.8
Okamoto, H.9
Sonoda, H.10
Watanabe, M.11
Nakagama, H.12
Yokota, J.13
-
81
-
-
84937073193
-
Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer
-
Matsumura T, Sugimachi K, Iinuma H, Takahashi Y, Kurashige J, Sawada G, Ueda M, Uchi R, Ueo H, Takano Y, Shinden Y, Eguchi H, Yamamoto H, et al. Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer. Br J Cancer. 2015; 113:275-81
-
(2015)
Br J Cancer
, vol.113
, pp. 275-281
-
-
Matsumura, T.1
Sugimachi, K.2
Iinuma, H.3
Takahashi, Y.4
Kurashige, J.5
Sawada, G.6
Ueda, M.7
Uchi, R.8
Ueo, H.9
Takano, Y.10
Shinden, Y.11
Eguchi, H.12
Yamamoto, H.13
-
82
-
-
85003952957
-
Protein content and functional characteristics of serumpurified exosomes from patients with colorectal cancer revealed by quantitative proteomics
-
Chen Y, Xie Y, Xu L, Zhan S, Xiao Y, Gao Y, Wu B, Ge W. Protein content and functional characteristics of serumpurified exosomes from patients with colorectal cancer revealed by quantitative proteomics. Int J Cancer. 2017; 140:900-913
-
(2017)
Int J Cancer
, vol.140
, pp. 900-913
-
-
Chen, Y.1
Xie, Y.2
Xu, L.3
Zhan, S.4
Xiao, Y.5
Gao, Y.6
Wu, B.7
Ge, W.8
-
83
-
-
84975490327
-
A novel TP53 pathway influences the HGS-mediated exosome formation in colorectal cancer
-
Sun Y, Zheng W, Guo Z, Ju Q, Zhu L, Gao J, Zhou L, Liu F, Xu Y, Zhan Q, Zhou Z, Sun W, Zhao X. A novel TP53 pathway influences the HGS-mediated exosome formation in colorectal cancer. Sci Rep. 2016; 6:28083
-
(2016)
Sci Rep
, vol.6
, pp. 28083
-
-
Sun, Y.1
Zheng, W.2
Guo, Z.3
Ju, Q.4
Zhu, L.5
Gao, J.6
Zhou, L.7
Liu, F.8
Xu, Y.9
Zhan, Q.10
Zhou, Z.11
Sun, W.12
Zhao, X.13
-
84
-
-
84938412771
-
KRAS-dependent sorting of miRNA to exosomes
-
Cha DJ, Franklin JL, Dou Y, Liu Q, Higginbotham JN, Demory Beckler M, Weaver AM, Vickers K, Prasad N, Levy S, Zhang B, Coffey RJ, Patton JG. KRAS-dependent sorting of miRNA to exosomes. Elife. 2015; 4:e07197
-
(2015)
Elife
, vol.4
-
-
Cha, D.J.1
Franklin, J.L.2
Dou, Y.3
Liu, Q.4
Higginbotham, J.N.5
Demory Beckler, M.6
Weaver, A.M.7
Vickers, K.8
Prasad, N.9
Levy, S.10
Zhang, B.11
Coffey, R.J.12
Patton, J.G.13
-
85
-
-
84927144443
-
Investigation of the roles of exosomes in colorectal cancer liver metastasis
-
Wang X, Ding X, Nan L, Wang Y, Wang J, Yan Z, Zhang W, Sun J, Zhu W, Ni B, Dong S, Yu L. Investigation of the roles of exosomes in colorectal cancer liver metastasis. Oncol Rep. 2015; 33:2445-53
-
(2015)
Oncol Rep
, vol.33
, pp. 2445-2453
-
-
Wang, X.1
Ding, X.2
Nan, L.3
Wang, Y.4
Wang, J.5
Yan, Z.6
Zhang, W.7
Sun, J.8
Zhu, W.9
Ni, B.10
Dong, S.11
Yu, L.12
-
86
-
-
79955652381
-
Amphiregulin exosomes increase cancer cell invasion
-
Higginbotham JN, Demory Beckler M, Gephart JD, Franklin JL, Bogatcheva G, Kremers GJ, Piston DW, Ayers GD, McConnell RE, Tyska MJ, Coffey RJ. Amphiregulin exosomes increase cancer cell invasion. Curr Biol. 2011; 21:779-86
-
(2011)
Curr Biol
, vol.21
, pp. 779-786
-
-
Higginbotham, J.N.1
Demory Beckler, M.2
Gephart, J.D.3
Franklin, J.L.4
Bogatcheva, G.5
Kremers, G.J.6
Piston, D.W.7
Ayers, G.D.8
McConnell, R.E.9
Tyska, M.J.10
Coffey, R.J.11
-
87
-
-
84874031607
-
Proteomic Analysis of Exosomes from Mutant KRAS Colon Cancer Cells Identifies Intercellular Transfer of Mutant KRAS
-
Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ. Proteomic Analysis of Exosomes from Mutant KRAS Colon Cancer Cells Identifies Intercellular Transfer of Mutant KRAS. Mol Cell Proteomics. 2013; 12:343-55
-
(2013)
Mol Cell Proteomics
, vol.12
, pp. 343-355
-
-
Demory Beckler, M.1
Higginbotham, J.N.2
Franklin, J.L.3
Ham, A.J.4
Halvey, P.J.5
Imasuen, I.E.6
Whitwell, C.7
Li, M.8
Liebler, D.C.9
Coffey, R.J.10
-
88
-
-
84999084587
-
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes
-
Dou Y, Cha DJ, Franklin JL, Higginbotham JN, Jeppesen DK, Weaver AM, Prasad N, Levy S, Coffey RJ, Patton JG, Zhang B. Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes. Sci Rep. 2016; 6:37982
-
(2016)
Sci Rep
, vol.6
, pp. 37982
-
-
Dou, Y.1
Cha, D.J.2
Franklin, J.L.3
Higginbotham, J.N.4
Jeppesen, D.K.5
Weaver, A.M.6
Prasad, N.7
Levy, S.8
Coffey, R.J.9
Patton, J.G.10
Zhang, B.11
-
89
-
-
84981333239
-
Exosomes from human colorectal cancer induce a tumor-like behavior in colonic mesenchymal stromal cells
-
Lugini L, Valtieri M, Federici C, Cecchetti S, Meschini S, Condello M, Signore M, Fais S. Exosomes from human colorectal cancer induce a tumor-like behavior in colonic mesenchymal stromal cells. Oncotarget. 2016; 7:50086-50098. doi: 10.18632/oncotarget.10574
-
(2016)
Oncotarget
, vol.7
, pp. 50086-50098
-
-
Lugini, L.1
Valtieri, M.2
Federici, C.3
Cecchetti, S.4
Meschini, S.5
Condello, M.6
Signore, M.7
Fais, S.8
-
90
-
-
20444453596
-
Human Colorectal Cancer Cells Induce T-Cell Death Through Release of Proapoptotic Microvesicles: Role in Immune Escape
-
Huber V, Fais S, Iero M, Lugini L, Canese P, Squarcina P, Zaccheddu A, Colone M, Arancia G, Gentile M, Seregni E, Valenti R, Ballabio G, et al. Human Colorectal Cancer Cells Induce T-Cell Death Through Release of Proapoptotic Microvesicles: Role in Immune Escape. Gastroenterology. 2005; 128:1796-804
-
(2005)
Gastroenterology
, vol.128
, pp. 1796-1804
-
-
Huber, V.1
Fais, S.2
Iero, M.3
Lugini, L.4
Canese, P.5
Squarcina, P.6
Zaccheddu, A.7
Colone, M.8
Arancia, G.9
Gentile, M.10
Seregni, E.11
Valenti, R.12
Ballabio, G.13
-
91
-
-
84905503012
-
Therapeutic targeting of microRNAs: current status and future challenges
-
Li Z, Rana TM. Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov. 2014; 13:622-38
-
(2014)
Nat Rev Drug Discov
, vol.13
, pp. 622-638
-
-
Li, Z.1
Rana, T.M.2
-
92
-
-
41149172340
-
Phase I Clinical Trial of Autologous Ascites-derived Exosomes Combined With GM-CSF for Colorectal Cancer
-
Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H, Li G. Phase I Clinical Trial of Autologous Ascites-derived Exosomes Combined With GM-CSF for Colorectal Cancer. Mol Ther. 2008; 16:782-90
-
(2008)
Mol Ther
, vol.16
, pp. 782-790
-
-
Dai, S.1
Wei, D.2
Wu, Z.3
Zhou, X.4
Wei, X.5
Huang, H.6
Li, G.7
-
93
-
-
84964445423
-
Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism
-
Zhao H, Yang L, Baddour J, Achreja A, Bernard V, Moss T, Marini JC, Tudawe T, Seviour EG, San Lucas FA, Alvarez H, Gupta S, Maiti SN, et al. Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. Elife. 2016; 5:e10250
-
(2016)
Elife
, vol.5
-
-
Zhao, H.1
Yang, L.2
Baddour, J.3
Achreja, A.4
Bernard, V.5
Moss, T.6
Marini, J.C.7
Tudawe, T.8
Seviour, E.G.9
San Lucas, F.A.10
Alvarez, H.11
Gupta, S.12
Maiti, S.N.13
-
94
-
-
85015383370
-
Total Extracellular Small RNA Profiles from Plasma, Saliva, and Urine of Healthy Subjects
-
Yeri A, Courtright A, Reiman R, Carlson E, Beecroft T, Janss A, Siniard A, Richholt R, Balak C, Rozowsky J, Kitchen R, Hutchins E, Winarta J, et al. Total Extracellular Small RNA Profiles from Plasma, Saliva, and Urine of Healthy Subjects. Sci Rep. 2017; 7:44061
-
(2017)
Sci Rep
, vol.7
, pp. 44061
-
-
Yeri, A.1
Courtright, A.2
Reiman, R.3
Carlson, E.4
Beecroft, T.5
Janss, A.6
Siniard, A.7
Richholt, R.8
Balak, C.9
Rozowsky, J.10
Kitchen, R.11
Hutchins, E.12
Winarta, J.13
-
95
-
-
67651252158
-
Urinary Markers in Colorectal Cancer
-
Feng B, Yue F, Zheng MH. Urinary Markers in Colorectal Cancer. Adv Clin Chem. 2009; 47:45-57
-
(2009)
Adv Clin Chem
, vol.47
, pp. 45-57
-
-
Feng, B.1
Yue, F.2
Zheng, M.H.3
-
96
-
-
84986231564
-
Association between Oxidative DNA Damage and Risk of Colorectal Cancer: Sensitive Determination of Urinary 8-Hydroxy-2'-deoxyguanosine by UPLC-MS/MS Analysis
-
Guo C, Li X, Wang R, Yu J, Ye M, Mao L, Zhang S, Zheng S. Association between Oxidative DNA Damage and Risk of Colorectal Cancer: Sensitive Determination of Urinary 8-Hydroxy-2'-deoxyguanosine by UPLC-MS/MS Analysis. Sci Rep. 2016; 6:32581
-
(2016)
Sci Rep
, vol.6
, pp. 32581
-
-
Guo, C.1
Li, X.2
Wang, R.3
Yu, J.4
Ye, M.5
Mao, L.6
Zhang, S.7
Zheng, S.8
-
97
-
-
85019141222
-
Urinary 5-Aminolevulinic Acid Concentrations as a Potential Tumor Marker for Colorectal Cancer Screening and Recurrence
-
Kamada Y, Murayama Y, Ota U, Takahashi K, Arita T, Kosuga T, Konishi H, Morimura R, Komatsu S, Shiozaki A, Kuriu Y, Ikoma H, Nakanishi M, et al. Urinary 5-Aminolevulinic Acid Concentrations as a Potential Tumor Marker for Colorectal Cancer Screening and Recurrence. Anticancer Res. 2016; 36:2445-50
-
(2016)
Anticancer Res
, vol.36
, pp. 2445-2450
-
-
Kamada, Y.1
Murayama, Y.2
Ota, U.3
Takahashi, K.4
Arita, T.5
Kosuga, T.6
Konishi, H.7
Morimura, R.8
Komatsu, S.9
Shiozaki, A.10
Kuriu, Y.11
Ikoma, H.12
Nakanishi, M.13
-
98
-
-
84988434181
-
The reliable assurance of detecting somatic mutations in cancer-related genes by next-generation sequencing: the results of external quality assessment in China
-
Zhang R, Ding J, Han Y, Yi L, Xie J, Yang X, Fan G, Wang G, Hao M, Zhang D, Zhang K, Lin G, Li J. The reliable assurance of detecting somatic mutations in cancer-related genes by next-generation sequencing: the results of external quality assessment in China. Oncotarget. 2016; 7:58500-58515. doi: 10.18632/oncotarget.11306
-
(2016)
Oncotarget
, vol.7
, pp. 58500-58515
-
-
Zhang, R.1
Ding, J.2
Han, Y.3
Yi, L.4
Xie, J.5
Yang, X.6
Fan, G.7
Wang, G.8
Hao, M.9
Zhang, D.10
Zhang, K.11
Lin, G.12
Li, J.13
|